CUE BIOPHARMA INC. -

Cue Biopharma Announces Upcoming Scientific Presentations at the Society for Immunotherapy of Cancer’s (SITC) 39th Annual Meeting

04 10 2024 09:00:00 提供 Nasdaq GlobeNewswire

Cue Biopharma Announces Pricing of $12.0 Million Public Offering

26 9 2024 23:26:30 提供 Nasdaq GlobeNewswire

Cue Biopharma Announces Proposed Public Offering

26 9 2024 23:10:15 提供 Nasdaq GlobeNewswire

Cue Biopharma Announces Proposed Public Offering

26 9 2024 16:27:02 提供 Nasdaq GlobeNewswire

Cue Biopharma Appoints Industry Veteran Lucinda Warren as Chief Business Officer

09 9 2024 08:00:00 提供 Nasdaq GlobeNewswire

Cue Biopharma to Present at The Promise of Interleukin-2 Therapy Conference

03 9 2024 08:00:00 提供 Nasdaq GlobeNewswire

Cue Biopharma Reports Second Quarter 2024 Financial Results and Recent Business Highlights

19 8 2024 16:05:00 提供 Nasdaq GlobeNewswire

Cue Biopharma to Host Business Update Call and Webcast

13 8 2024 08:00:01 提供 Nasdaq GlobeNewswire

Cue Biopharma Announces Strategic Prioritization of Autoimmune Programs Enabling Optimization of Workforce and Reduction of Capital Requirements

25 7 2024 16:05:00 提供 Nasdaq GlobeNewswire

Cue Biopharma Presents Updated Data from Phase 1 Trial of CUE-101 in Recurrent/Metastatic HPV+ Head and Neck Cancer at the 2024 ASCO Annual Meeting

04 6 2024 08:00:00 提供 Nasdaq GlobeNewswire

Cue Biopharma to Present at Two Upcoming Investor Healthcare Conferences in June 2024

03 6 2024 08:00:00 提供 Nasdaq GlobeNewswire

Cue Biopharma Reports First Quarter 2024 Financial Results and Recent Business Highlights

09 5 2024 16:05:01 提供 Nasdaq GlobeNewswire

Cue Biopharma to Present at the 20th Annual PEGS Boston Summit

08 5 2024 08:00:00 提供 Nasdaq GlobeNewswire

Cue Biopharma to Participate in Fireside Chat at The Citizens JMP Life Sciences Conference

07 5 2024 08:00:00 提供 Nasdaq GlobeNewswire

Cue Biopharma to Present at the 2024 American Society of Clinical Oncology (ASCO) Annual Meeting

24 4 2024 10:01:00 提供 Nasdaq GlobeNewswire

Cue Biopharma Reports Fourth Quarter and Full Year 2023 Financial Results and Updated Business Highlights

08 4 2024 16:05:00 提供 Nasdaq GlobeNewswire

Cue Biopharma to Host Business Update Call and Webcast

02 4 2024 08:00:00 提供 Nasdaq GlobeNewswire

Cue Biopharma’s Lead Clinical Asset, CUE-101, to be Featured at the 2024 Multi-disciplinary Head and Neck Cancers Symposium

29 2 2024 10:00:00 提供 Nasdaq GlobeNewswire

Cue Biopharma to Present Corporate Update at the Oppenheimer 34th Annual Healthcare Life Sciences Conference

06 2 2024 08:00:00 提供 Nasdaq GlobeNewswire

Cue Biopharma to Present at the JMP Securities Hematology and Oncology Summit

22 11 2023 08:00:00 提供 Nasdaq GlobeNewswire